Jennifer Lushis is a seasoned professional in the field of Quality Assurance, currently serving as Vice President at Pelthos Therapeutics. With extensive experience, Jennifer has held prominent roles including Director and Abecma Quality Product Lead at 2seventy bio, and Director of Quality Operations for External Manufacturing at Taysha Gene Therapies. Prior positions include Sr. Director of Quality Assurance at Veloxis Pharmaceuticals and Director of Quality Assurance at Braeburn Pharmaceuticals. Jennifer holds a degree in Management, specializing in Business Administration and Management from Maryville University of Saint Louis.